Please login or register first to view this content.
Infectious Diseases Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Biktarvy Approval Expanded to Include Younger Children With HIV-1
Flucelvax Quadrivalent Approval Expanded to Include Younger Patients
Convalescent Plasma Unlikely to Improve Outcomes in Severe COVID-19
COVID-19 Infection Risk Drops With Increasing Immunity Within Family
MPR Weekly Dose Podcast Episode 96
REGEN-COV Gets Priority Review for COVID-19 Treatment, Prophylaxis
Drug Metabolism May Be Suppressed in Patients With Inflammatory Conditions
Protection Against SARS-CoV-2 Wanes Months After BNT162b2 Vaccination
Glucose-Regulating Drugs Aid COVID-19 Outcomes in Patients With Diabetes
Infection Risk Does Not Seem to Differ Among Biologics for Psoriasis
FDA Panel Votes on Maribavir for Post-Transplant CMV Infection
BNT162b2 Protects Against COVID-19 Hospitalization for Up to 6 Months
Study Confirms Virulence of SARS-CoV-2 Variants of Concern
AstraZeneca Seeks EUA for Long-Acting Antibody Combo for COVID-19 Prevention
Posoleucel Gets Orphan Drug Status for Virus-Associated Hemorrhagic Cystitis
Lotrimin, Tinactin Spray Products Recalled Due to Presence of Benzene
Inhaled Corticosteroids May Reduce Severity, Frequency of Recurrent Croup
Prophylactic Topical Antimicrobial Tx Cuts Infection Risk After Mucosal Head and Neck Surgery
